Intravaginal and intrarectal microbicides to prevent HIV infection

Balzarini, Jan; Van Damme, Lut
February 2005
CMAJ: Canadian Medical Association Journal;2/15/2005, Vol. 172 Issue 4, p461
Academic Journal
Analyzes the therapeutic use of intravaginal and intrarectal microbicides for preventing HIV infection. Potential mechanisms for HIV transmission across mucosal epithelium; Discussion on the buffering agents and detergents that comprise nonspecific microbicides; Investigation of a variety of anionic substances that target the adsorption and fusion process of the virus; Mechanism of action of HIV-specific microbicides.


Related Articles

  • Antiretroviral Agents Used by HIV-Uninfected Persons for Prevention: Pre- and Postexposure Prophylaxis. Grant, Robert M. // Clinical Infectious Diseases;May2010 Supplement 3, Vol. 50, pS96 

    Prophylactic use of antimicrobial agents and microbicides has been proven for many infections, including surgical, gastrointestinal, upper respiratory, and meningococcal infections. Antiretroviral therapy for pregnant women prevents mother-to-child transmission of human immunodeficiency virus...

  • HIV-1: Viral assembly inhibitors on the horizon. Brazil, Melanie // Nature Reviews Drug Discovery;Sep2005, Vol. 4 Issue 9, p716 

    Reports that scientists have identified a molecule that interferes with the formation of HIV particles in vitro. Possibility that such findings could lead to the development of a new class of HIV drugs that slow or prevent the progression of HIV in patients; Use of phage-display screening to...

  • A Brief Update on the AIDS Epidemic. Kopansky-Giles, Deborah // Journal of the American Chiropractic Association;Dec2004, Vol. 41 Issue 12, p40 

    Presents a brief update on the AIDS epidemic. Approximation made by the Joint United Nations Program on HIV/AIDS on the number of people who were infected with HIV by December 2003; Success of the Highly Active Antiretroviral Therapy in reducing viral load in people living with AIDS; Role played...

  • AIDS gel's failure calls prevention approach into question. Bolognesi, Natasha // Nature Medicine;Mar2007, Vol. 13 Issue 3, p230 

    The article reports on the failure of microbicide Ushercell in preventing HIV infection. In earlier trials, Ushercell seemed both safe and effective. However, in a large phase 3 trial of 1,333 sexually active women, the researchers discovered that more women using the gel had become infected...

  • Lower pill burden, novel therapies coming for HIV. LoBuono, Charlotte // Drug Topics;3/21/2005, Vol. 149 Issue 6, p24 

    A treatment goal for physicians treating HIV and AIDS is to find simpler anti-retroviral drug regimens that can be utilized less frequently to help improve adherence and prevent the complications caused by resistance to these products. The trend in early 2005 is toward fewer pills with less...

  • The HIV/AIDS Epidemic.  // Population Reports;Apr99, Vol. 27 Issue 1, p6 

    States that the extent of the AIDS epidemic underscores the urgent need for condoms. How HIV affects the human body; How HIV/AIDS spreads; Prospects for AIDS in sub-Saharan Africa and developing countries of Asia.

  • Discovery May Lead to New HIV Drugs, Says Jefferson Medical College Virologist.  // Ascribe Newswire: Medicine;8/7/2002, p5 

    Scientists at London's King's College and their colleagues elsewhere uncovered the identity of a gene that prevents HIV from reproducing. Researchers found that a gene called CEM15 is a natural inhibitor of HIV, acting as a brake on HIV's development. They showed that biologically tying up a...

  • Criteria for detecting and understanding changes in the risk of HIV infection at a national level in generalised epidemics. Garnett, G. P.; Gregson, S.; Stanecki, K. A. // Sexually Transmitted Infections;Apr2006 Supplement 1, Vol. 82, pi48 

    Identification of causes of changes in prevalence and incidence of HIV at a national level is important for planning future prevention and intervention needs. However, the slow progression to disease and the sensitive and stigmatising nature of the associated behaviours can make this difficult....

  • A new analytical framework of 'continuum of prevention and care' to maximize HIV case detection and retention in care in Vietnam. Fujita, Masami; Poudel, Krishna C.; Thi, Nhan Do; Duc, Duong Bui; Van, Kinh Nguyen; Green, Kimberly; Minh, Thu Nguyen Thi; Kato, Masaya; Jacka, David; Thanh, Thuy Cao Thi; Thanh, Long Nguyen; Jimba, Masamine // BMC Health Services Research;2012, Vol. 12 Issue 3, p1 

    Background: The global initiative 'Treatment 2.0' calls for expanding the evidence base of optimal HIV service delivery models to maximize HIV case detection and retention in care. However limited systematic assessment has been conducted in countries with concentrated HIV epidemic. We aimed to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics